|Replenish Depleted Nutrients|
|Reduce Side Effects|
|Potential Negative Interaction|
See also How to Use and Precautions sections.
Your healthcare professionals (e.g., doctor or pharmacist) may already be aware of any possible drug interactions and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
This drug should not be used with the following medication because a very serious interaction may occur: dofetilide.
If you are currently using the medication listed above, tell your doctor or pharmacist before starting quinapril with hydrochlorothiazide.
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: aliskiren, cisapride, drugs affecting the bone marrow (e.g., azathioprine), drugs that can increase dizziness (e.g., phenobarbital, narcotic pain relievers such as codeine), diazoxide, lithium, probenecid, drugs that may increase the level of potassium in the blood (such as ARBs including losartan/valsartan, birth control pills containing drospirenone), other "water pills" (diuretics such as amiloride, furosemide, triamterene), gold injections.
This product contains magnesium which can interfere with the absorption of some medications. For example, if you are taking a tetracycline antibiotic, take it at least 2 hours apart from quinapril/hydrochlorothiazide. If you are taking a quinolone antibiotic (e.g., ciprofloxacin, levofloxacin) or a bisphosphonate (e.g., risedronate), consult your pharmacist for the proper times to take those medications apart from quinapril/hydrochlorothiazide. This is not a complete list.
A very serious reaction may occur if you are getting injections for bee/wasp sting allergy (desensitization) and are also taking quinapril with hydrochlorothiazide. Make sure all your doctors know which medicines you are using.
Check the labels on all your medicines (e.g., cough-and-cold products, diet aids, nonsteroidal anti-inflammatory drugs-NSAIDs for pain/fever reduction) because they may contain ingredients that could increase your blood pressure (e.g., pseudoephedrine, phenylephrine) or reduce the effect of this medication (e.g., ibuprofen, naproxen). Ask your pharmacist about the safe use of those products.
This product can affect the results of certain lab tests. Make sure laboratory personnel and all your doctors know you use this drug.
This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
Copyright © 2015 Aisle7. All rights reserved. Aisle7.com
RxAnswers™ is a copyrighted combined product from Aisle7 and First DataBank, Inc.
Drug information is selected from data included with permission and copyrighted by First DataBank, Inc. This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional. Always seek the advice of your healthcare professional if you have any questions about this product or your medical condition. This information is not intended as individual medical advice and does not substitute for the knowledge and judgment of your healthcare professional. This information does not contain any assurances that this product is safe, effective or appropriate for you.
This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.
There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.
Aisle7 and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.
Information expires June 2016.